From: A framework for assessing the risk of resistance for anti-malarials in development
 | drug resistancea | pfcrt b | pfmdr1 c | pfdhfr d | pfdhps e | pfcytb |  | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Strain | CHQ | SUL | PYR | CYC | MEF | ATO | 72 | 73 | 74 | 75 | 76 | 86 | 184 | 1034 | 1042 | 1246 | copy | 16 | 51 | 59 | 108 | 164 | 436 | 437 | 581 | 613 | 268 | Origin | MR4 number | Ref. |
NF54 | S | S | S | S | S | S | C | V | M | N | K | N | Y | S | N | D | 1 | A | N | C | S | I | S | G | A | A | Y | Imported | MRA-100 | [25] |
D6 | S | S | S | S | R | S | C | V | M | N | K | N | Y | S | N | D | 1 | A | N | C | S | I | A | A | A | A | Â | Cloned from Sierra Leone I/CDC | MRA-285 | [26] |
HB3 | S | S | R | S | S | S | C | V | M | N | K | N | Y | S | D | D | 1 | A | N | C | N | I | S | A | A | A | Â | Cloned from Honduras I/CDC | MRA-155 | [27] |
7 G8 | R | S | R | R |  |  | S | V | M | N | T | N | F | C | D | Y | 1 | A | I | C | N | I | S | G | A | A |  | Cloned from IMTM 22 (Brazil) | MRA-152 | [28] |
Dd2 | R | R | R | R | R | Â | C | V | I | E | T | Y | Y | S | N | D | 4 | A | I | R | N | I | F | G | A | S | Â | Cloned from W2-Mef (Indochina III/CDC) | MRA-150 | [29] |
V1/S | R | R | R | R | Â | Â | C | V | I | E | T | Y | Y | S | N | D | Â | A | I | R | N | L | F | G | A | T | Â | Cloned from V1 (Vietnam) | MRA-176 | [30] |
K1 | R | R | R | R | Â | Â | C | V | I | E | T | Y | Y | S | N | D | 1 | A | N | R | N | I | S | G | G | A | Â | Thailand | MRA-159 | [31] |
FCB | R | Â | S | R | Â | Â | C | V | I | E | T | Y | Y | S | N | D | 2 | V | N | C | T | I | Â | Â | Â | Â | Â | Columbia | MRA-309 | [32] |
TM90C2B | R | Â | R | Â | R | R | C | V | I | E | T | N | F | S | N | D | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | S | Thailand | N/A | [3] |